Annual report pursuant to Section 13 and 15(d)

Stockholders' Deficit (Details Narrative)

Stockholders' Deficit (Details Narrative) - USD ($)												1 Months Ended	6 Months Ended	12 Months Ended
Stockholders' Deficit (Details Narrative) - USD ($)	Sep. 27, 2017	Aug. 23, 2017	Aug. 14, 2017	Jul. 25, 2017	Feb. 22, 2017	Dec. 20, 2016	Sep. 06, 2016	Aug. 26, 2016	Jul. 19, 2016	Jul. 11, 2016	Jul. 06, 2016	Jul. 31, 2016	Jul. 10, 2016	Dec. 31, 2017	Dec. 31, 2016	Oct. 05, 2017	Mar. 15, 2017	Mar. 13, 2017	Feb. 07, 2017
Common stock shares authorized														500,000,000	500,000,000				500,000,000
Common stock par value					$ 0.01									$ 0.01	$ 0.01	$ 0.01
Preferred stock shares authorized														5,000,000					5,000,000
Preferred stock par value														$ 0.01
Warrants to purchase common stock									42,478						55,092,381		2,056
Warrant exercise price per share														$ 0.276
Proceeds from issuance public offering									$ 7,500,000
Number of warrants to cover over-allotments									675
Common stock shares issued														19,750,844	186,692
Common stock shares outstanding														19,750,844	186,692
Indebtedness amount														$ 7,800,000
Number of common stock shares issued, shares									42,478					1,167,479	12,815
Common stock for cashless exercise of outstanding warrants															108
Debt converted into share														18,285,517
Debt converted into share, value														$ 7,300,000	$ 2,231,829
Shares issued to settle notes and warrants																		26,667
Shares issued to settle notes and warrants, value																		$ 400,000
Warrants to purchase common stock, value																	$ 57,868
Number of common stock shares issued, value															11,819,265
Common stock shares issued for professional service		33,334
Value of professional service fee		$ 118,493												$ (161,003)	$ (73,335)
Number of restricted stock shares forfeited and cancelled														5,373	91
Dividend yield rate															500.00%
Expected volatility rate															168.00%
Risk free rate of interest															1.88%
Recognized stock option expense														$ 303,046	$ 1,107,487
Restricted Stock [Member]
Stock issued price per share														$ 3.75
Recognized stock option expense														$ 244,768
Unrecognized compensation														400,000
Stock Options [Member]
Recognized stock option expense														200,000	$ 900,000
2007 Equity Plan [Member]
Unrecognized compensation														$ 400,000
Weighted average period														1 year 28 days
2017 Equity Plan [Member]
Number of common stock shares issued, shares															1,618
Recognized stock option expense															$ 300,000
Consultants [Member]
Value of professional service fee															$ 73,000
Number of restricted stock shares forfeited and cancelled															586
Former Employee [Member]
Number of common stock shares issued, shares				8,333
Number of common stock shares issued, value				$ 42,510
Employees and Directors [Member]
Number of restricted stock issued			181,933
Number of restricted stock returned to treasury			5,373
Board of Directors [Member] \| Maximum [Member]
Common stock shares authorized														3,000,000,000
Common Stock [Member]
Conversion of stock, shares converted													373	370,446	25,836
Shares converted into debt															12,816
Debt converted into share, value															$ 128
Number of common stock shares issued, value
Number of restricted stock issued														181,933
Common stock shares issued for professional service														41,667	586
Value of professional service fee														$ 417	$ 6
December 2015 Warrant [Member]
Fair value adjustment of warrants												$ 1,700,000
December 2015 Warrant [Member] \| Exchange Agreement [Member]
Warrants to purchase common stock										14,337
Exchange Warrants [Member]
Warrants to purchase common stock										167,555,446
Common Stock [Member]
Conversion of stock, shares converted															57,555
Warrant [Member]
Warrant exercise price per share														$ 0.0418
Number of warrant issued														1,955,338,400
Series B Preferred Stock [Member]
Conversion of stock, shares converted							12,742
Series C Preferred Stock [Member]
Conversion of stock, shares converted													260
Preferred stock shares outstanding										8,740
Series G Preferred Stock [Member]
Preferred stock shares authorized														14,000	14,000
Preferred stock par value														$ 0.01	$ 0.01
Conversion of stock, shares converted										13,793					5,232
Stock issued price per share										$ 1,000
Preferred stock shares outstanding														215	215
Stock conversion price per share											$ 13.50
Warrant exercise price per share											$ 0.0038
Proceeds from issuance public offering						$ 8,300,000
Preferred stock value														$ 2	$ 2
Preferred stock shares issued														215	215
Preferred Stock [Member]
Preferred stock, voting rights											Stockholders representing approximately 74% of the voting power of the Company approved the Exchange.
Series E Preferred Stock [Member] \| Epinex Diagnostics, Inc. [Member]
Number of preferred shares cancelled								45,000
Series H Preferred Stock [Member]
Preferred stock shares authorized														14,202	14,202
Preferred stock par value														$ 0.01	$ 0.01
Conversion of stock, shares converted						8,346								7,785	2,331
Stock issued price per share						$ 1,000
Preferred stock shares outstanding														60	10,019
Stock conversion price per share						$ 2.70
Preferred stock shares designated						12,350
Proceeds from issuance public offering						$ 11,800,000
Offering costs						$ 500,000
Number of common stock shares issued, shares														7,785
Debt converted into share														370,446
Shares converted into debt														2,174
Stock converted into debt														$ 2,200,000
Debt converted into share, value														2,700,000
Preferred stock value															$ 100
Preferred stock shares issued														60	10,019
Series H Preferred Stock [Member] \| Underwriters [Member]
Warrants to purchase common stock						15,247
Warrant exercise price per share						$ 50.70
Series F Preferred Stock [Member]
Preferred stock shares authorized														1,750,000	1,750,000
Preferred stock par value														$ 0.01	$ 0.01
Preferred stock shares outstanding														1,750,000	0
Shares converted into debt	59,829
Debt converted into share, value	$ 174,097
Preferred stock value	$ 1,750,000													$ 17,500
Preferred stock shares issued														1,750,000	0
Series F Preferred Stock [Member] \| Genomas, Inc. [Member]
Preferred stock, voting rights	one vote
Stock conversion price per share	$ 29.25
Debt converted into share	59,829
Preferred stock value	$ 174,097
Preferred stock price per share for unpaid dividend	$ 1.95
Reserve Stock Split [Member]
Number of common stock shares issued, shares					526